Te-An Lee

409 total citations · 1 hit paper
7 papers, 214 citations indexed

About

Te-An Lee is a scholar working on Infectious Diseases, Molecular Biology and Oncology. According to data from OpenAlex, Te-An Lee has authored 7 papers receiving a total of 214 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Te-An Lee's work include Glycosylation and Glycoproteins Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Te-An Lee is often cited by papers focused on Glycosylation and Glycoproteins Research (2 papers), COVID-19 Clinical Research Studies (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Te-An Lee collaborates with scholars based in Taiwan, United States and Ethiopia. Te-An Lee's co-authors include Yun‐Ju Lai, Dhimiter Bello, Chi-Hong Chao, Shing‐Jyh Chang, Jung-Mao Hsu, Hirohito Yamaguchi, Chia-Wei Li, Wen‐Cheng Chou, Yi‐Ling Lin and Chun‐Che Liao and has published in prestigious journals such as Cancer Research, Cancer Letters and Frontiers in Medicine.

In The Last Decade

Te-An Lee

7 papers receiving 212 citations

Hit Papers

Biomarkers in long COVID-19: A systematic review 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Te-An Lee Taiwan 6 116 73 48 42 34 7 214
Jenny Meinhardt Germany 5 122 1.1× 102 1.4× 30 0.6× 10 0.2× 16 0.5× 10 206
Seyyedmohammadsadeq Mirmoeeni Iran 8 79 0.7× 35 0.5× 20 0.4× 14 0.3× 8 0.2× 19 141
Amirhossein Azari Jafari Iran 8 79 0.7× 35 0.5× 20 0.4× 14 0.3× 8 0.2× 19 141
Arina Tamborska United Kingdom 8 128 1.1× 98 1.3× 82 1.7× 12 0.3× 41 1.2× 13 285
Angela Napolitano Italy 7 147 1.3× 165 2.3× 53 1.1× 20 0.5× 16 0.5× 15 279
Medha Tandon United States 9 303 2.6× 145 2.0× 18 0.4× 11 0.3× 5 0.1× 18 356
Anne Strigli Germany 5 49 0.4× 43 0.6× 72 1.5× 29 0.7× 44 1.3× 6 207
Yuanjun Qin China 6 94 0.8× 48 0.7× 32 0.7× 23 0.5× 8 0.2× 13 299
Lena J. Lippert Germany 5 57 0.5× 31 0.4× 22 0.5× 7 0.2× 5 0.1× 8 106

Countries citing papers authored by Te-An Lee

Since Specialization
Citations

This map shows the geographic impact of Te-An Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Te-An Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Te-An Lee more than expected).

Fields of papers citing papers by Te-An Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Te-An Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Te-An Lee. The network helps show where Te-An Lee may publish in the future.

Co-authorship network of co-authors of Te-An Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Te-An Lee. A scholar is included among the top collaborators of Te-An Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Te-An Lee. Te-An Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Lee, Te-An, Wen‐Cheng Chou, Cheng‐Chang Chang, et al.. (2025). Regulation of PD-L1 glycosylation and advances in cancer immunotherapy. Cancer Letters. 612. 217498–217498. 6 indexed citations
2.
Lee, Te-An, et al.. (2024). Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy. Cancer Research. 84(6). 800–807. 30 indexed citations
3.
Lai, Yun‐Ju, et al.. (2023). Biomarkers in long COVID-19: A systematic review. Frontiers in Medicine. 10. 1085988–1085988. 128 indexed citations breakdown →
4.
Lee, Te-An, et al.. (2022). Prognostic serum biomarkers in cancer patients with COVID-19: A systematic review. Translational Oncology. 21. 101443–101443. 4 indexed citations
5.
Chou, Wen‐Cheng, Te-An Lee, Linghui Wang, et al.. (2022). Deglycosylation of SLAMF7 in breast cancers enhances phagocytosis.. PubMed. 12(10). 4721–4736. 8 indexed citations
6.
Lai, Yun‐Ju, Chi-Hong Chao, Chun‐Che Liao, et al.. (2021). Epithelial-mesenchymal transition induced by SARS-CoV-2 required transcriptional upregulation of Snail.. PubMed. 11(5). 2278–2290. 24 indexed citations
7.
Liao, Chun‐Che, Shih‐Han Wang, I‐Jung Lee, et al.. (2021). Hyperglycosylated spike of SARS-CoV-2 gamma variant induces breast cancer metastasis.. PubMed. 11(10). 4994–5005. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026